Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 3

1(33.3%)

3Total

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT05736523Active Not Recruiting

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

Role: collaborator

NCT03733418Completed

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Role: collaborator

NCT06329843Recruiting

Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro

Role: collaborator

NCT04912544Not ApplicableCompleted

Facilitating Patient Communication During Noninvasive Ventilation

Role: collaborator

NCT01796574Not ApplicableCompleted

Ketogenic Diet for Refractory Status Epilepticus

Role: collaborator

All 6 trials loaded